The “Intelligent Imaging” revolution
On the occasion of “Health & Wellness Week” of Expo 2020 Dubai, on Bracco Group, as Official Gold Sponsor of the Italian Pavilion, presented the latest applications of artificial intelligence in the medical-scientific field during the forum “Intelligent Imaging: Beyond the Future and Back to Mind” which was attended by an exceptional expert: Charles Kahn, Professor and Vice President of the Department of Radiology at the University of Pennsylvania and Director of the scientific journal Radiology:Artificial Intelligence. “Artificial intelligence”, he has declared Charles Kahn, “Can help add value to diagnostic radiology throughout the consultation process. AI can help select the most appropriate exam, optimize the way the exam is performed, and improve image quality. Radiologists can apply AI systems to detect abnormalities, make a diagnosis and provide recommendations for follow-up. ”
AIforCovid
During the works it was also illustrated AIforCOVID the non-profit multicentre research project carried out by Bracco Imaging and from Italian Diagnostic Center, the healthcare facility of the Group led by Diana Bracco. A project aimed at predicting, thanks to the database AI-for-COVID Imaging Archive which already contains thousands of radiological tests and which is available to the entire international scientific community, the clinical evolution of the COVID-19 disease.
Based on artificial intelligence applied to diagnostic imaging, the project is enabling doctors and healthcare professionals to have the database available AI-for-COVID Imaging Archive of radiographic images of Covid patients useful for understanding in advance the course of the disease in patients affected by COVID-19 allowing personalized and more timely therapies. They spoke at the meeting Dr. Lorenzo Preda, Full Professor of Radiology at the University of Pavia and head of the Radiology Division at the IRCCS Fondazione Policlinico San Matteo; Dr. Marco Ali, Research Operation Manager press CDI e Scientific Advisor per Bracco Imaging; Dr. Giovanni Valbusa, Project Manager R&D Bracco Imaging. Bracco Imaging is the central organ of the development of the Ai-for-COVID study; Dr. Isabella Castiglioni, Full Professor of Medical Physics and Machine Learning at the University of Milan-Bicocca and co-founder and Honorary President of the startup DeepTrace Technology.
“Today’s artificial intelligence algorithms,” he explained lsabella Castiglioni, “Are able to extract a large number of quantitative characteristics from medical images, often invisible to the naked eye, and to associate them with clinical data to inform doctors about the diagnosis, prognosis and response to therapy. However, these tools are developed for the most part as research tools and the transition to becoming medical devices, mandatory to bring them to the patient, is indeed a complex challenge. From design to design, development and production, medical artificial intelligence software must undertake a path of compliance with regulations today similar to that of a drug. The Italian Diagnostic Center, in collaboration with the start-up DeepTrace Technologies, a spin off of the University School of Pavia “, specified the professor Castiglioni, “Has made this important step and can now relate his experience relating to memory clinic, a path of personalized medicine predictive of neurodegenerative diseases that assists the neurologist with the informed decision of a CE marked artificial intelligence medical device “.